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The field of public health is replete with mathematical models and numerical targets. In the case of 
disease eliminations, modelled projections and targets play a key role in evidencing elimination 
futures and in shaping actions in relation to these. Drawing on ideas within science and technology 
studies, we take hepatitis C elimination as a case for reflecting on how to think with mathematical 
models and numerical targets as ‘performative actors’ in evidence-making. We focus specifically on 
the emergence of ‘treatment-as-prevention’ as a means to trace the social and material effects that 
models and targets make, including beyond science. We also focus on how enumerations are made 
locally in their methods and events of production. We trace the work that models and targets do in 
relation to three analytical themes: governing; affecting; and enacting. This allows us to situate 
models and targets as technologies of governance in the constitution of health, which affect and are 
affected by their material relations, including in relation to matters-of-concern which extend beyond 
calculus. By emphasising models and targets as enactments, we draw attention to how these devices 
give life to new enumerated entities, which detach from their calculative origins and take flight in new 
ways. We make this analysis for two reasons: first, as a call to bring the social and enumeration 
sciences closer together to speculate on how we might think with models and targets differently and 
more carefully; and second, to encourage an approach to science which treats evidencing-making 
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Numbers smack of precision. Numbers communicate a sense of control. Numbers speak a common 
language which transcends contexts. This is the magic often said to be afforded by numbers.  
 
But we can think of numbers and numbering practices in multiple ways. For instance, we can think of 
enumerations as entities which are materialised differently according to their means, methods and 
events of production. There are multiple ideas condensed into this last sentence: enumerations as 
entities; enumerations as materialised; and enumerations as situated, that is, as things which are open 
to different eventuation according to their localised knowledge-making. This kind of thinking 
orientates towards what numbers do, what they become, and the effects they make, through their 
implementations, for instance, as predictions, targets, and metrics in intervention and policy. More 
specifically, this kind of thinking appreciates how numbers are afforded agency through their 
entanglements in practices.  We can therefore appreciate enumerations as situated interventions 
(Rhodes and Lancaster, 2019a). Accordingly, we propose thinking of enumerations, and here 
mathematical models and numerical targets, as performative actors with governing potential in the 
constitution of health. 
 
Treating numbers as performative means that they are never ‘just numbers’. They become lively, and 
do more. In a performativity approach, numbers are not simply ‘out there’, and crucially, they do not 
pre-exist their enumerating. This means that they are not as stable or as singular as they appear, and 
they cannot be assumed to represent an anterior reality. Rather, numbers are made in the materials 
of science and other practices, and furthermore, they make effects, including beyond calculus, in the 
‘real worlds’ of action, intervention and policy. Whereas there is a mainstream tendency to theorise 
action as an exclusively human capacity (done in the work of those producing, implementing and using 
enumerations), we are theorising action as an effect of relations which also entangle nonhuman actors 
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(Latour, 1987; Law, 2014), including the work that is done in and through enumerations (Verran, 2005; 
Callon and Law, 2005). 
 
The performativity of enumerations 
So, how do models, targets and other forms of enumeration perform? Drawing on ideas within science 
and technologies studies, we foreground our analysis by accentuating two performative effects of 
numbering. First, models and targets emerge in social and material relations, and tacitly embed as 
well as reproduce these through their assumptions and calculations. Global models of energy 
forecasting, for instance, can reproduce the normative assumptions of their architects, thereby 
orientating projections as well as shaping policies in particular directions (Wynne, 1984; Aykut, 2019). 
Likewise, climate change forecasts illustrate how models build their projections, with policy 
consequences, according to the normative and calculative assumptions underpinning them, especially 
in relation to how they theorise mechanisms of climate change (Jasanoff, 2010). What goes into 
models, shapes what comes out, in a series of recursive moves. From the outset then, we can treat 
models and targets as entangled effects of the assemblages of actors and practices which materialise 
them. Importantly, such assemblages extend beyond science, and the laboratories producing models 
locally, to incorporate social (and global) relations, incorporating institutions, systems, technologies, 
discourses, and worldviews (Law, 2012; Mccann and Ward, 2012; Aykut 2019).  
 
Second, models and targets materially equip as well as shape actions in the present in light of the 
futures they project (Callon, 1998; Mackenzie, 2006; Michael, 2000). This means that models and 
targets do not merely represent, but make, realities. We can draw here on the foundational work of 
Michel Callon and others which traces how modelled economic projections shape the markets in 
which they are entangled (Callon and Numiesa, 2005; Callon, 2007; Mackenzie, 2006). This work 
accentuates models as performative devices in the materialisation of practices. The model itself 
becomes an ‘engine’ of reality-making as it travels into different actor networks and is taken up and 
put-to-use as a tool of projection, prediction and planning (Mackenzie, 2006). In this orientation, 
model outputs – what comes out – shape the material-discursive contexts of future action and policy-
making, delimiting what becomes conceivable and possible. While oriented to possibility, models tend 
to close-down otherwise open and undetermined futures into actionable and plausible trajectories 
which are situated in relation to the particularities of the material present (Michael, 2000; Aykut, 
2019). Thus, in a performativity approach to enumeration, there is a twin emphasis on the relationality 





We contribute to this special focus of papers on mathematical modelling as social scientists. Our 
interest is not to debate the veracity of modelling methods or the findings produced by models. Our 
concern is less epistemological than ontological. We are interested in how the calculation devices of 
models and targets bring certain enumerations into being with certain social and material effects. 
Concentrating on mathematical models and numerical targets as they relate to the elimination of viral 
infection, and specifically hepatitis C and the invention of ‘treatment-as-prevention’, we consider 
what models and targets do; that is, how they are put-to-use and how they are made-to-matter as 
situated matters-of-concern (including beyond science). In what has become a ‘race to eliminate’ 
hepatitis C among other viruses, we wish step back for a moment to ask two questions: ‘what realities 
and effects do the enumerations of models and targets make?’; and ‘how are enumerations made 
locally in the materials, methods and events which produce them?’.     
 
Why ask these questions? Models and targets have become ubiquitous in fields of policy and risk 
governance, including in relation to financial and economic markets, climate change, environment, 
energy, water, food, and ‘natural’ and humanitarian disaster (Wynne, 1984; Callon, 1998; Mackenzie, 
2006; Jasanoff, 2010;  Landström et al., 2011; Aykut et al., 2019; Haines, 2019). The fields of global 
health and evidence-based health care are also replete with models and targets (Gunning-Schepers 
and Van Herten, 2000; Bauer, 2013). This is clearly apparent in global efforts to eradicate disease 
(WHO, 2015a,b, 2016a,b, 2017). The projected and targeted elimination of HIV and hepatitis C as 
public health threats are prime examples (WHO, 2016b,c; UNAIDS, 2014). Without projection, futures 
cannot be anticipated. Models and targets are forms of “anticipatory knowledge”, which “turn the 
future into an object of scientific enquiry and political intervention”, affording an “anticipatory 
governance” (Guston, 2014; Ayut et al., 2019: 2). Not only do models and targets delimit futures 
affecting the present, this is often a goal of models which seek to engage directly with policy and 
medical interventions. We can see this in the field of hepatitis C, where mathematical models and 
numerical targets entangle in a viral elimination assemblage which incorporates pharmaceuticals and 
policy proposals among its actors. Modelled projections and numerical targets intervene, governing 
the future-present in particular ways.  
 
We therefore take hepatitis C elimination as our case for reflecting on how to think with models and 
targets as performative actors in evidence-making and intervention. We invite modellers, disease 
elimination scientists, and policy-makers to think with us. We want to bring the social and 
enumeration sciences into dialogue to speculate on how we might think with models and targets 
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differently, and more carefully. This is an ontopolitical move, for if models and targets contribute to 
performing the worlds of health and viral elimination in particular ways, it is also possible to perform 
these worlds differently (Mol, 1999, 2002; Law, 2012). Specifically, we make three proposals. First, to 
think with models and targets as objects that are afforded agency as technologies of governance in 
the constitution of health and populations (governing). Second, to think with models and targets as 
affording life and effects which extend beyond their original calculative spaces (affecting). Third, to 
think with models and targets as devices which constitute new enumerated entities (enacting). Of 
course, these modes of governing, affecting and enacting are inseparable (as each entangle 
relationally). But each help us to instantiate how enumerations are materialised in practices (of 
science, intervention and policy) while at the same time materialise these.  
 
Models and targets in viral elimination 
Before we make our case for thinking with models and targets as modes of governing, affecting and 
enacting, we need to say a few words to situate a context for hepatitis C and its elimination. A now 
common narrative is to characterise the field of hepatitis C treatment as a site of rapid and dramatic 
technological change generating great promise. Pharmaceutical treatments for chronic hepatitis C – 
Direct-Acting Antivirals (DAAs) – promise near 100% cure of hepatitis C infection with near zero side-
effects (Dore and Feld, 2015; Falade-Nwulia et al., 2017). DAAs have moved from pharmaceutical 
development to clinical trial to implementation at an unprecedented pace. Their implementation, 
which began around 2014, marked a rupture from previous Interferon-based treatments 
characterised by poor cure rates and debilitating side-effects. DAAs perform a ‘new era’ of treatment 
optimism, characterised as ‘ground-breaking’ and ‘revolutionary’ potential (Banerjee and Reddy, 
2016; Gane, 2014; Grebely et al., 2017; Dore and Feld, 2015; Innes et al., 2015).  
 
Models and targets materialise hepatitis C treatment promise in the DAA era. Not only are DAAs 
enacted to afford the promise of cure among infected individuals, they potentiate a future without 
hepatitis C at the level of populations, territories, and nation states (Rhodes and Lancaster, 2019b). 
This population-level impact is evidence-made through mathematical models of theoretical projection 
(Hickman et al., 2015; Pitcher et al., 2018), in which the prevention potential of hepatitis C treatment 
curative outcomes is projected at a scale sufficient to reduce the pool of infections, and thus 
transmissions, in the population at risk, including accounting for rates of re-infection among those 
treated (Martin, Vickerman and Hickman, 2011). The publication of models theorising hepatitis C cure 
as having treatment-as-prevention effects is a foundational moment in evidence-making (Zeller et al., 
2010; Martin et al., 2011; Martin, Vickerman and Hickman, 2011). These models followed a wave of 
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excitement in the projection (Cohen, 2011; Cohen et al., 2011), and subsequent empirical evidencing 
via trials (Cohen et al., 2016), of treatment-as-prevention in the field of HIV, also heralded as ‘game-
changing’. Models of treatment-as-prevention continue to drive the field of hepatitis C intervention 
and policy, including in light of higher treatment cure rates resulting from pharmaceutical trials, and 
as part of wider assemblages of viral elimination promise (Martin et al., 2013; Hagan et al., 2013; 
Hellard et al., 2014; Innes et al., 2015; Razavi et al., 2017; Fraser et al., 2018; Ward et al., 2018; Scott 
et al., 2018; Zelenov et al., 2018; Kwon et al., 2019). Many of these models have also projected the 
intervention coverage required to meet prevention targets, including the additive effects of combining 
pharmaceutical treatments with other forms of prevention (Martin et al., 2013). There are also models 
of the cost-effectiveness of treatment-as-prevention investments (Martin et al., 2012, 2016; Scott et 
al., 2017, 2020; Cipriano and Goldhaber-Fiebert, 2018). In potentiating treatment-as-prevention and 
imagined futures in which hepatitis C is controlled, models “tantalise”: 
 
The advent of new hepatitis C virus treatments (DDAs) […] has ushered in an era of excitement 
about the possibility of eliminating HCV transmission. Tantalising theoretical mathematical 
models predicting dramatic reductions in HCV chronic prevalence and incidence, with scale-
up of HCV treatment for those at risk of transmission, have fuelled this optimism. (Martin, 
Vickerman and Hickman, 2017: 5; emphasis added). 
 
A second foundational moment in the transformation of hepatitis C cure is the enactment of 
treatment-as-prevention as viral elimination. Critical here, has been the invention of global viral 
elimination targets. In 2016, the World Health Organization (WHO) released its Global Health Sector 
Strategy on Viral Hepatitis. Embedded within an agenda of the United Nations to control, eliminate 
and eradicate preventable infectious diseases including malaria, HIV and tuberculosis (United Nations, 
2015), this Strategy set a goal to “eliminate viral hepatitis as a major public health threat by 2030”, 
and accordingly, set targets to achieve this globally (WHO, 2016b). The prime global targets for 
eliminating viral hepatitis are a 90% reduction in new cases and a 65% reduction in related deaths. 
These global disease elimination targets link to a range of service-level targets concerning intervention 
coverage in relation to diagnosis, prevention and treatment. The Strategy, for the first time in global 
health policy, imagined “a world where viral hepatitis transmission is halted” (WHO, 2016b:.21).  
 
Through their entanglements with targets, modelled projections equip and format transactions in 
intervention and policy (Callon, 1998), thereby shaping the viral elimination contexts of which they 
are a part. Models and targets thus work together as ‘arrangements of prediction’ to make-up viral 
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elimination futures (Schubert, 2015). We can trace, for example, modelled evidence of treatment-as-
prevention into global as well as national viral elimination strategies (WHO, 2014, 2016b; 
Commonwealth of Australia, 2016; All-Party Parliamentary Group on Liver Health, 2018; Health 
Protection Scotland, 2019). Moreover, not only do models shape the invention of targets but they are 
put-to-use and calibrated in relation to these as a means of projecting the interventions and 
investments required to actualise elimination promise (Razavi et al., 2017, 2019; Scott et al., 2017, 
2018; Ward et al., 2018; Gountas et al., 2018; Hefferman et al., 2019; Kwon et al., 2019; Walker et al., 
2019). There is then, a recursive relationship between models which evidence-make elimination 
potential, the invention of viral elimination targets, and models which evidence elimination progress 
in relation to these.  
 
Governing 
Our first point, and perhaps our main one, is that enumerations are afforded particular governing 
powers. The data products of meta-analyses, systematic reviews and mathematical models, for 
instance, generate particular potentials as evidence-making interventions regarding their relative 
epistemic and rhetorical value, apparent stability, objectivity and precision, data combinability, and 
translational mobility (Robson, 1992; Hansen and Porter, 2012; Daston and Galison, 2007; Moreira, 
2007). A body of work investigates how enumerations have governmentality potential in relation to 
health and welfare (Rose, 1991; Porter, 1995; Miller, 2001; Shore and Wright, 2015; Merry, 2011; 
Davis et al., 2012; Hansen and Porter, 2012), including through targets, standards, rankings, 
projections, predictions, measures, metrics and audits (Castels, 1999; Power, 2007; Strathern, 2000; 
Sauder and Espeland, 2009; Erikson, 2012). The development of statistics and probability, in particular, 
has enabled enumerated governance through various measures of ‘risk’, which have helped create 
and control boundaries of ‘population’ and ‘health’ in relation to quantifiable biosocial ‘norms’ 
(Castels, 1991; Rose, 1991; Armstrong, 1995; Rowse, 2009). Enumerations, and especially projections 
and predictions, function to tame risk, chance and uncertainty, thus affording security through 
calculus (Hacking, 1990; Castels, 1999). As noted, “By producing information about what has not yet 
happened”, projections “reduce social complexity and constitute problems for acting in the present” 
(Aykut et al., 2019: 2; Mallard and Lakoff, 2011). Enumerated projections standardise and control by 
closing down unknowns, as sources of dis-ease, into a governable present.  
 
Virtual precision, vague predicates, and the ‘elimination paradox’ 
Let us consider how enumerations enact diseases as governable. Here, we consider specifically how 
proportionalities have a power-of-acting. As we have noted, there are two prime WHO global targets 
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which constitute the elimination of hepatitis C as a public health threat by 2030: a 90% reduction in 
new infections and a 65% reduction in related deaths. Each of these targets afford virtual precision in 
the face of uncertainty. Both 90% and 65% are expressions of proportionality in relation to a ratio 
(90:100, and 65:100), and thus simplify the ratio of two quantities in a field (Verran, 2015; Holtrop, 
2018). The numerator, which simplifies the sum of the infections or deaths being reduced, is evidence-
made (and is nothing without) the denominator, which represents the whole, the total number in the 
field. The enumerated reality is made relationally. Percentages enact parts in relation to a whole. 
Elimination is constituted (in part, for there are other targets) as a percentage reduction against a 
population of an unknown absolute number of infections and deaths. The denominator is an empirical 
unknown in many settings, especially given the complex history of hepatitis C transmissions in diverse 
populations and how the totality of absolute cases (embodied in actual people) remain hidden from 
the gaze of epidemiology and diagnostic testing (Foura et al., 2018; Grebely et al., 2019). Percentages 
focus attention on “the possibility of de-/increase of the proportion rather than on the constituents 
themselves or the mathematics of their relation” (Holtrop, 2018: 9; emphasis added). Proportionality 
is a means to governing uncertainty at distance, here in relation to multiple unknowns regarding 
referent cases and their relations. The uncertainties of how to ‘actually’ enumerate hepatitis C 
incidence and death in quantities that are measurable (Larney et al., 2015; Trickey et al., 2019; Grebely 
et al., 2019), as well as the complexities of social and material relations which affect local patterns of 
incidence and illness, are tamed (masked) through proportionality.  
 
Verran (2015) notes that proportionalities can offer technical solutions to the ‘sorites paradox’, also 
known as the paradox of heaps and piles, which arises in vague predicates, such as when does a heap 
or pile, such as a pile of rice, no longer become a heap or pile, as units are progressively taken away? 
Viral elimination also arises in vague predicates. When does elimination occur? How many cases of 
infection have to be removed for elimination to come into being? Conversely, when does elimination 
cease to exist? The WHO targets do not constitute viral elimination in relation to absolute numbers or 
thresholds. For instance, viral elimination is not articulated as maintaining zero cases globally (disease 
eradication) or in epidemiological terms as the stopping of transmission in a defined space or time 
(disease elimination) (Dowdle, 1998; Dore, 2018). Proportional targets solve an elimination paradox 
in the face of case and threshold imprecision. They render a “vague whole” into “specific units” as a 
means to enact a “governance” (Verran, 2015: 370). A new entity of elimination is refashioned, one 
materially different from past epidemiological definitions (Dowdle, 1998). This new version of disease 
elimination is constituted as an unknown number of infections deemed ‘manageable’ and ‘acceptable’ 
relative to public health ‘threat’ (WHO, 2016b; Dore, 2018). This vague set of predicates is nonetheless 
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performed as a virtual precision, thus enabling governmentality potential, through its enumeration as 
a proportion. The proportion itself becomes, and makes certain enough, elimination. As we have noted 
elsewhere of numerical targets, enumerations do not need empirical precision to perform authority 
(Lancaster, Rhodes and Rance, 2019). We have then, a case of enumerated projections governing a 
material present in relation to an imagined future through practices of virtual precision giving rise to 
virtual elimination. 
 
Elimination governance, states, and citizenship 
We can further trace how global viral elimination strategy and targets quantify and qualify in particular 
ways. The WHO Global Health Strategy qualifies viral hepatitis as a visible and major problem worthy 
of global attention in relation to universal standards of health and sustainable development. This, in 
combination with the invention of apparently quantifiable elimination targets, transforms the object 
of hepatitis C from a matter of dis-ease to a technical controllable problem of vital significance 
(Lancaster, Rhodes and Rance, 2019). Enumeration performs a problem that ‘counts’ at the same time 
as making it amenable to control through counting. Furthermore, numerical targets enact particular 
realities in the futures they project, which impact in the present, including through policy and 
intervening (Michael, 2000).  We should therefore ask ‘what kind worlds do elimination targets 
make?’, and put another way, ‘what kind of now is made possible through practices of elimination 
futuring?’.  
 
Here, our example accentuates how numerical targets contribute to constituting a world in relation 
to viral elimination, wherein targets become technologies of transnational governance in relation to 
a global standard (Hansen and Porter, 2012).  This is not a neutral process for it makes up populations, 
states, geographies and citizenships in particular ways in relation to particular enumerated values. It 
is also a relational process in which the governing effects of global targets are made possible through 
their connections in a hinterland of practices (Law, 2004, 2009) which combine to coordinate a ‘glocal’ 
viral elimination reality, including through nation-state sign-ups to global strategies, pharmaceutical 
industry and government relations, treatment investments and scale-ups, diagnostic and testing 
innovations, community campaigns, and implementation science. A global ‘race’ to eliminate hepatitis 
C is held in place by this hinterland of viral elimination practices (Lancaster and Rhodes, 2020). We can 
see how nation-states and other territories are made ‘accountable’ through targets in relation to the 
global elimination race, enacting elimination citizenship. This new world is constituted of elimination 
states, wherein territories are refashioned as parts in relation to an imagined whole constituted by an 
‘acceptable’ level of reduced infection (Dore, 2018). Many territories fall short of inclusion against this 
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new norm. The focus of targets on shifts in proportionalities (90% reductions in infections and 65% 
reductions in deaths) deflects attention from the complexity of the social-material relations enabling 
or disabling such change, especially considering the rich diversity of territories making-up the globe. 
Rather, attention shifts to the constitution of nation-states as ‘elimination-states’ in relation to their 
relative positioning against virtual elimination targets (90% and 65%) in abstract measures of 
elimination time (usually 2020 or 2030). Models project the progress of nation-states against these 
virtual measures, and whether they appear to be “on track”, “ahead”, or “unlikely” to meet global 
targets in time (Kwon et al., 2019; Walker et al., 2019; Scott et al., 2019; Razavi et al., 2019).    
 
Figure 1, for instance, qualifies the world in relation to viral elimination targets. Based on modelling 
and epidemiological data synthesised by the Polaris Observatory (2019), 95 countries are marked red 
with elimination projected as “unachievable”, 10 are marked amber and “working towards” 
elimination, and six are green and “on track”.  Half as many countries are “on track” according to these 
data in 2019 than in 2017 (See also Razavi et al., 2019). At the time we submitted this paper for 
publication, the UK, Australia and Georgia were among the countries projected as being “on track” to 
achieve the WHO elimination targets by 2030 (Razavi et al., 2019). By the time we came to revise our 
paper, these countries were projected, on account of 2019 data and changing treatment rates, to 
achieve the WHO incidence target by 2038, 2040 and 2041 respectively (Polaris Observatory, 2019). 
Different models produce different elimination states in space and time (Ward et al., 2018; Walker et 
al., 2019; Kwon et al., 2019). The numerical constitution of elimination states affords nations and 
governments a relative capital in a global field, but is not stable, with multiple elimination realities co-
existing as well as in friction with one another (See also below). Figure 2 similarly qualifies nation-
states in Africa in relation to quantifications of viral elimination. Again, states are constituted in 
relation to their relative success (green) or failure (red) on a “scorecard” of viral hepatitis elimination 
potential. On the indicator relating to WHO global viral hepatitis testing targets, all 42 countries 
submitting data are scored “not on track”, with only eight countries indicated as showing progress in 
developing national hepatitis treatment programmes.   
 
Insert: Figures 1 and 2 
 
The articulation of targets as accountability devices in relation to a universal standard is also explicit 
in WHO’s 2019 progress report on global viral elimination which is sub-titled “Accountability for the 
global health sector strategies, 2016-2021” (WHO, 2019). The mixed success in reaching global targets 
in relation to hepatitis, HIV and sexually transmitted infections is used as a platform to advocate for 
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action to ‘accelerate towards elimination’ and as an ‘opportunity to fill gaps in implementation’ so as 
to ‘reach the targets’ (WHO, 2019: 2). The report shows the viral hepatitis elimination targets in light 
green to indicate “on track, with gaps”, though in relation to hepatitis C there are no percentage 
reductions calculated against the twin targets of reduced infections (of 90% by 2030) and deaths (of 
65% by 2030). Subsumed within a singular category of viral hepatitis, the report produces a 
“scorecard” which indicates the global viral elimination targets in green and “on track”, despite the 
data indicating a decline in incident infections being unavailable for hepatitis C (WHO, 2019: 24). We 
see the performative potential of targets as a mobilising resource for audit, accountability and action, 
ordering the world in relation to hepatitis C in particular ways, even in the relative absence of empirical 
evidence. Here, targets enact a virtual precision through the performance of evidence-based 
intervention, but do so with incredible latitude. With hepatitis C targets unsubstantiated given the 
unavailability of numerical estimates, it is the targets themselves which are given life to act and which 
do the qualification work. Targets, because they qualify as well as enumerate, do not always need 
numerical data to perform.  
 
To further illustrate our points about the power-of-acting of global targets, we can note how numerical 
targets are incorporated in community advocacy campaigns. Elsewhere, we have traced how targets 
are mobilised in visualisations of viral elimination as part of the World Hepatitis Alliance “NOhep” 
campaign (Lancaster and Rhodes, 2020). The NOhep movement seeks to act as an “accountability and 
advocacy tool ensuring governments take necessary measures to the targets outlined in the WHO 
Global Health Sector Strategy” (NOhep, 2018a). Figure 3 gives an illustration (NOhep, 2018b). In this 
visualisation, the actors which qualify elimination potential (through different kinds of intervening) 
are bounded between a baseline of quantification and a numerical target with quantified outcome. 
Elimination – which results from the various actors and actions coming together – requires 
enumeration, and more specifically targets, to become known. Other infographics in the campaign 
also enact elimination actors as enumerated entities against numerical targets (see: NOhep, 2018b). 
These enumerations do their work, affecting power, through the campaign without mobilising 
‘actualised’ numbers. Taken together, we can see that numerical targets are afforded governmentality 
potential through their enactments in different actor networks – epidemiology, modelling, policy, and 
community – and that the power of numbers resides in their relations.  
 





Appreciating enumerations as forces of governance accentuates how models and targets generate 
effects in ways that extend beyond their original modes of calculation. Our next point emphasises that 
the knowledge produced in mathematical models circulates beyond the model into new actor 
networks without necessarily transporting all of its methodological apparatus and epistemological 
assumptions (Callon, 2007; Latour, 1987; Law, 2009). Enumerations have material life and form 
beyond their calculus. How models give life to numerical targets of disease elimination, which then 
generate agency and authority of their own, is an example (see above). Indeed, enumerations are 
especially mobile objects, partly enabled by their enactment as ‘universals’ in an assumed common 
mathematical language said to translate across contexts (Porter, 1995). It is therefore important to 
ask how enumerations adapt and transform according to how, where, and for what purpose they 
travel, especially as they circulate from their original fields of inscription (Latour, 1987). This means 
that we do not treat enumerations as ‘immutable mobiles’ of singular and fixed precision but as 
‘mutable mobiles’ of multiple potential with unforeseen effects (Latour, 1987; Law, 2004; Myers, 
2015). Critically, this accentuates enumerations materialised as situated concerns. Enumerated 
projections escape, and extend beyond, their mathematical models and targets as they are actualised 
locally in relation to matters of social and political concern, as well as desire. This brings us to 
appreciate models as devices of anticipation and affect and not merely of reasoned calculus (Myers, 
2015). What enumerations do is contingent upon how they affect, and are affected by, the material 
worlds in which they circulate. This accentuates two things: a multiplicity of enumeration effect 
potential beyond matters of fact and calculus; and potential frictions in how scientists and other actors 
engage with, and make use of, projections.  
 
Material transformations  
We have proposed that a foundational moment in the evidence-making of viral elimination is the 
modelled projection of ‘treatment-as-prevention’. The first such published model theorised that 
hepatitis C elimination was not possible without population-level risk reduction, necessitating 
treatment at sufficient coverage to attenuate the effects of re-infections among people who 
continued to inject drugs (Zeller et al., 2010). A second model, published in 2011 (Martin et al., 2011), 
then modified in light of altering treatment cures rates (Martin et al., 2013), was “the first” to 
transform hepatitis C from merely treatable to an object preventable at “modest” and “achievable” 
treatment rates (Martin et al., 2011: 1141). This latter model projected, for instance, that an annual 
treatment rate of just 20 infections per every 1000 persons who injected drugs resulted in a 62% 
reduction in prevalence after 10 years in a chronic prevalence scenario of 20% (Martin et al., 2011). 
This model has taken flight, helping to establish a treatment-as-prevention standard for the field. 
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Through the evidence made by the model, treatment-as-prevention has become enacted as doable 
and within reach, an anticipated reality, and this has afforded the object of treatment-as-prevention 
a power-of-acting and capacity for travel (Rhodes and Lancaster, 2020). Through anticipation, we 
move from mere possibilities (theoretical propositions) to potentialities (futures felt in the now). The 
model of treatment-as-prevention is actualised into the immediate present through rapid policy and 
intervention transformations. For instance, clinical practice guidelines rearticulate treatment as an 
object of prevention (WHO, 2014, 2016d; EASL, 2015, 2016), and national strategies draw on modelled 
projections to set viral elimination targets (Commonwealth of Australia, 2018; Health Protection 
Scotland, 2019). Multiple models have flowed, transforming their field of attention beyond mere 
treatment-as-prevention to viral elimination potentials. Models move around the globe to evidence 
elimination states and futures, while contributing to target setting and calibrating projections in 
relation to these (see above).  
 
Upon release from its model, therefore, the object of treatment-as-prevention entangles as affective 
matter into elimination concern. Through its travels into new actor networks enumerated treatment-
as-prevention becomes something more, a new entity, a re-assembled object of elimination with the 
power to affect, and be affected by, its emergent context. The viral elimination assemblages, in which 
models and targets entangle as technologies of anticipation, incorporate the fervour of community, 
media, policy and industry excitement which makes up the ‘race to eliminate’ (Lancaster and Rhodes, 
2020), and generates affective flow (Adams, Murphy and Clarke, 2009; Myers, 2015; Schubert, 2015). 
Treatment-as-prevention makes new attachments as it is ‘let go’ from its mathematical origins 
(Gomart and Hennion, 2000; Rhodes and Lancaster, 2020). The power-of-acting of enumerated 
projection is moved in its materialisations, from maths and calculus to action and affect, always 
becoming more than ‘just a number’.  
 
Consider, for instance, the following headlines released from the National Health Service of England 
as technologies of anticipation which energise viral elimination concern in the global race to eliminate: 
“Our aim is to rid England of the hepatitis C virus”; “NHS England sets out plans to be first in the world 
to eliminate Hepatitis C”; “NHS England plans to eliminate Hepatitis C in England by 2025, five years 
earlier than World Health Organisation goals”; and “The NHS will find and cure tens of thousands more 
people with hepatitis C as part of a ground-breaking deal that could help England become the first 
country in the world to eliminate the deadly virus” (NHS England, 2019a,b,c,d). Enumerated 
projections generated by mathematical models live among variable forms of projection beyond 
science – targets, policy proposals, advocacy interventions, community actions, hopes, desires – which 
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entangle together to make up an assemblage of potential embodied as anticipation.  This hits home 
our key point: when appreciated as performative actors, enumerations are not “stable states” but 
“relational beings” (Verran, 2015: 367).  
 
Qualculation and anticipation 
What lessons can we draw from noticing that enumerations take flight beyond their calculative 
origins? First, we can appreciate that enumerations are made up in qualifications and not only 
quantifications. A calculation is not merely arithmetical in form (Callon and Law, 2005). The 
materialisation of enumerations in situated practices – from community actions to national targets 
and global policies – is a process of qualification. Upon leaving their laboratories of production, 
enumerations are qualified in one way or another as matters-of-concern in relation to the 
epistemological claims made about them, the values and effects they afford, and how they are put-
to-use by knowledge consumers (Moreira, 2007). Following Callon and Law (2005), models and targets 
are best understood as qualculations: they rely upon and generate qualitative judgements and 
qualifications, and they work to produce qualified as well as quantified abstractions and projections. 
 
Second, we can consider the potential for non-qualculability. One form of non-qualculability which 
has a bearing on the power-of-acting of models and targets is rarefaction (Callon and Law, 2005). This 
removes the resources and relations required for qualculus, through a ‘letting go’ in favour of affect, 
such as embodied passion, emotion, attachment, suffering, and feeling (Gomart and Hennion, 2000). 
We are proposing that anticipation is one such affect generated by enumerated projections. 
Anticipation reaches beyond ‘evidence-based’ calculation. In their ‘letting go’ as affective matter, 
projections alter metaphysically as well as metaphysically alter their present (Verran, 2015). Projected 
futures of great promise, of hope, of game-changing potential, of a new world without infection, 
generate affects which are felt in, and make, the present. As we noted earlier, models and targets 
govern as forms of anticipatory regime, for they orientate to a future which makes responses in the 
now (Adams, Murphy and Clarke, 2009; Mallard and Lakoff, 2011; Guston, 2014). Thinking of 
enumerated projection as qualculation and as affective matter pushes us beyond calculus to the 
incorporation of vital concerns. It helps us notice the work that enumerations do beyond maths and 
science. Treating enumerations as qualculations and affects also attends to the latitude afforded to 
models and targets as they travel as virtual precisions into practices (see above). We propose that it is 
this flexibility, this relative release from empirical actuality, this letting go, that affords enumerations 
movement in how they enact ‘evidence’ in ways which matter (Hacking, 1995; Sismondo, 1999; Myers, 
2015). This is to say, that what matters in practice is how models and targets move things (affects, 
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people, policies) to make things (like viral elimination) happen. There is a multiverse of evidences and 
effects generated by models which are rarely considered within the world of evidence-based calculus.       
 
Enacting 
Lastly, we extend our point about enumerations as ‘relational beings’ by honing attention to how the 
methods of models themselves act as performative devices. We see the methods of enumerated 
projection as object making machines (Mackenzie, 2006). This thinking focuses attention on how the 
calculative practices of models (and other forms of synthesis and simulation) do not merely re-
assemble the data upon which they draw, but enact new entities through their enumerations. 
Following Michel Callon’s work on the performativity of economic models (2007), we draw attention 
to two translational processes in modelling practices. First, there is a process of detachment of entities 
arranged into a different single space. This involves disentangling data from their networks, domains 
and sources into a new network, or database, to create the model. Second, there is the 
implementation of a common language or operating principle within this new data space which 
enables comparison across the incorporated data which have been drawn from multiple calculative 
spaces. Both these steps involve calculation and qualification (that is, qualculation), wherein data is 
handled and presented in new ways to enact enumerated entities of a different kind (Callon, 2007; 
Moreira, 2007; Bauer, 2013; Verran, 2015).  
 
In models and simulations there is considerable work involved to bring “heterogeneous bits and 
pieces” into a “patterned network that overcomes their resistance” to produce a new “end product” 
(Law, 1992: 381). Removing ambiguity and complexity from data elements fed into a model, for 
instance, involves ‘fixing’ categories through processes of ‘stabilisation’ and ‘disambiguation’, and 
these are necessary qualification steps to make data categories and models work (Rapp, 1999: 208; 
Bauer, 2013). Qualifications play an important role in navigating the ‘mess’ of model building 
(Sismondo, 1999). There seems greater latitude, as well as qualification and subjective judgement, in 
models engaging with data subject to empirical uncertainties and in models of greater abstraction 
(Hacking, 1995). In their modifications – via synthesis, equations and graphical platforms – different 
forms of data are on the move, and take on additional properties, giving rise to new entities with new 
governing powers. This draws attention to enumerated projections as effects of ‘within model’ (and 
not only ‘beyond model’) enactment, constituted in particular ‘methods assemblages’ of evidence-
making (Latour and Woolgar, 1979; Law, 2014). 
 
Enumerating entities of viral elimination 
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The object transformations enacting hepatitis C treatment as prevention, and further, as elimination, 
emerge in relation to situated community and policy concerns (see above) but are also made-up inside 
the modelling. This is achieved through a qualculative process which works to detach and then re-
arrange various heterogeneous enumerations into a new form. Prime among the denominators 
incorporated into this new numerator are quantifications of ‘cure rate’. Quantifications of cure rate 
entangle with other data inputs of variable calculative origin and form, such as: population size; drug 
use initiation, cessation and duration; infection incidence and prevalence; intervention effect and 
coverage; and risk. All of these quantifications are subject to qualifications, especially in the face of 
their empirical uncertainty, and are managed through extrapolations, approximations, hypotheticals, 
negotiations and subjective judgements.  
 
In this journal issue, for instance, is an example of a model projecting hepatitis C prevention impact in 
Tanzania where few of the quantified inputs originated in local calculations, many were products of 
subjective judgement, and some were not based in enumerations at all (Scott et al., 2020). DAA 
treatments were not available in this setting, and so the model assumed that treatment 
commencement “will occur for 80% of people following diagnosis, based on the WHO target, which 
was considered feasible due to the simplicity of the new treatments” (Scott et al., 2020). Here, the 
model imports a global target to act as data in the absence of any quantifiable indicator. As we have 
argued above, quantifiable targets do not need ‘actual numbers’, or numerical precision, to make their 
performances ‘count’, that is, to work as projections of a future viral elimination reality. And as models 
shift to projecting viral elimination potentials, they fold in projected targets (of unknown veracity and 
precision locally; see above) into their making of new projections (Razavi et al., 2017, 2019; Fraser et 
al., 2018; Kwon et al., 2019; Scott et al., 2018; Ward et al., 2018; Gountas et al., 2018; Hefferman et 
al., 2019; Walker et al., 2019). We emphasise that models are always doing ontological work to enact 
new entities (and realities) through their qualculative moves, rather than corresponding to pre-
existing data inputs (whatever their veracity) or to an anterior reality. 
 
Let us give brief mention to two further examples of ‘within model’ enactment. First, we can re-visit 
the model of treatment-as-prevention (Martin et al., 2011). What affords this model its power-of-
acting in constituting viral elimination as an ‘anticipated reality’ that is felt ‘within reach’ can be 
located in the maths. The model calculates treatment engagement rates differently to previous 
attempts to model treatment-as-prevention (Zeller et al., 2010). Rather than assuming a set 
percentage of a population treated each year, which results in treating increasingly fewer people as 
the pool of infections decline, the model works with a rate (for instance, 20 treated infections per 
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1000 persons who inject drugs) which assumes treating the same number of people each year from 
the denominator population for a set period, which generates projections of smaller and more 
manageable numbers of treated cases required to bring about an overall prevention effect. The 
elimination potentials afforded by the model are embodied within its methods assemblage and not 
only in the assemblages of viral elimination which give life to these enumerations upon their release. 
 
Next, we can consider the example of an interim evaluation of the hepatitis C elimination programme 
in Georgia (Walker et al., 2019). Here, modelling moves a future potential into an evaluation, a 
judgement in the now, on the basis of projecting the prevention impacts of past treatment rates into 
a future, which is indexed in relation to set viral elimination targets. The model projects a short fall, 
despite large impacts, in prevention effects, estimating the need for an approximate four-fold increase 
in future treatment rates (from 1,000 to over 4,000 patients initiating treatment per month) to meet 
national hepatitis C prevention targets by 2020. The study offers a dynamic model which associates 
rates of decline in hepatitis C incidence with a diminishing prevalence of the population at risk (people 
who inject drugs), which pre-dated the implementation of the national viral elimination programme, 
and which enhances the prevention impact of treatment in the infected population (which also 
includes iatrogenic infections) going forwards (Walker et al., 2019: 8). In announcing publication of 
the projections that Georgia will be “unlikely” to meet its national elimination targets of 2020 but is 
“nevertheless still on track” to meet the WHO elimination targets of 2030, the lead modeller 
speculates: “We evaluated the incredible scale-up of treatment for hepatitis C and progress towards 
elimination in Georgia. Will they be the first country to reach the WHO HCV elimination target?” 
(Twitter, 2019). This model projects differently to others, including the non-dynamic models of the 
Polaris Observatory (See Figure 1) which indicate that Georgia will not meet the WHO elimination 
incidence targets until 2041, despite previous projections that Georgia was ‘on track’. It can be difficult 
to tell, especially for non-modellers, how differences in projections are effects of calculation input. 
Commenting on the different projections produced by the models, one speculation proffered, in a 
Twitter conversation involving modellers, is that “the key part” of the dynamic model (Walker et al., 
2019) was “fitting the transmission model to show how the population of people who inject drugs is 
changing in Georgia” which “makes a huge difference to the path of elimination that is not captured 
in Polaris models” (Twitter, 2019). In this example, we can appreciate how ‘within model’ practices 
might shape quantifications relating to the dynamics of the denominator populations which alter 
elimination projections. Importantly, these qualifications are not separable from, but entangle with, 
‘beyond model’ qualifications, here relating to how a nation-state is enacted in a global viral 




In their handling of data of different form and empirical certainty, models incorporate a mix of 
qualified quantifications and quantified qualifications. Hepatitis C intervention models might work to 
combine, for instance, empirical quantifications with values of more or less certainty (such as difficult-
to-make estimates of risk group population size and risk cessation rates) with theoretical hypotheses 
(such as causal pathways of risk reduction), heuristics (such as cascades of care), analogies (such as 
comparisons between populations, contexts and countries), and policy proposals (such as targets in 
relation to intervention). In their blending of different data forms, in their entangling of the apparent 
actual and the abstract, and in their extending of the present into the future, models create partial 
connections and make transformations (Hacking, 1995). We therefore think of models less as devices 
of reflection (of objects and actualities ‘out there’) but of invention (eventuating new objects and 
realities ‘in here’). In viral elimination models, we jump from variable cure rates of individual 
treatment effect – actualised empirically in particular surveys or trials, among particular populations, 
in particular locations – to hypothesised enumerated entities of population prevention – actualised in 
simulations according to new calculative routines and material realities. We move from individuals to 
populations, from empirics to abstracts, from presents to futures, from cure rates to incident cases, 
from treatment to prevention to elimination. A metaphysical altering occurs (Verran, 2015). 
 
Concluding 
We propose that noticing the performative work of models and targets (and other enumerations) 
enacts a form of hesitation (Stengers, 2018). It encourages a slowing down, a momentary stepping 
back in the race to eliminate viral infection, to reflect critically on the effects that projected futures 
make, including in the now. Through the actions and effects of models and targets, a new material 
order of an imagined future is being enacted. Rather than valued in relation to their previous indexical 
lives – for instance, in relation to trials, surveys and other empirical routines – the values of 
denominators in a model shift into new numerators according to a different epistemic routine as an 
index of the future (Verran, 2015). On their escape from models, emergent enumerations – such as 
new entities of treatment-as-prevention and as elimination – have the potential to take flight, to 
travel, to transform, to have life through their relations in material worlds as matters-of-concern 
which extend beyond matters of maths, fact and science. We therefore think of enumerations not as 
mere numbers but as entities, as “relational beings”, which are afforded life in relation to “some actual 




Why does this matter? The proposal to think with models and targets as relational beings and as 
performative actors is helpful because it brings us closer to noticing what models and targets actually 
do. As we have argued, it helps us notice how they govern, how they affect, how they enact. That is, 
how they make a material difference. These material effects are not easily noticed by an ‘evidence-
based’ science restricted to matters of epistemological concern (Rhodes and Lancaster, 2019a,b). 
Indeed, a particular epistemological concern of modellers is how to keep hold of enumerations that 
appear to take flight beyond the boundaries of ‘evidence-based’ probability (Rhodes and Lancaster, 
2020). The mutability, multiplicity and transformative potential of models, and the entities they 
produce as they travel into new networks, is unsettling for evidence-based science. But rather than 
thinking of mutable enumerations as a problem of evidence-based science we think of this as an 
affordance to knowing and acting differently.  
 
We propose that working with enumerations as qualculations and as affective matter invites a 
modelling science that does not seek to artificially separate quantification from qualification, or maths 
from materiality, or evidence and practice. Rather, a qualculative and affective science of modelling 
promises to learn from how enumerations are made and used in situated actualities, and this makes 
science more real. Thinking with models and targets ontologically, as ‘evidence-making’ interventions, 
helps appreciate how enumerations come to be and are made to matter. This, in turn, enables dialogue 
about the futures we are making through our science, how these govern, and the kind of futures we 
might wish to make. If the ways in which enumerations materialise in practices relates to situated 
concerns rather than empirical precisions, and if it is this which affords them their power-of-acting 
potential, this tells us that we need to engage with the qualculative flexibility of models and targets 
as ontopolitical interventions (Mol, 2002). This invites a more speculative, as well as more qualitative, 
science of futuring; a modelling science which also orientates to qualifications and affects, situated 
multiplicities of projection, and the democratisation rather than colonisation of anticipatory expertise 
(Stengers, 2018; Adams, Murphy and Clarke, 2009). Our focus moves from a concern for measurement 
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